Zur Rose Group
在场
Zur Rose Group 是一家在股票代码 ROSE (CH) 下上市的公司。
Zur Rose Group 在 2 个国家有直接业务。
高管
查看带有其 18 名主要高管的组织结构图
Zur Rose Group 搜索最多的简介
- Walter Hess, Chief Executive Officer
- Rongrong Hu, Director
- Stefan Feuerstein, Vice Chairman of the Board
创建提醒
跟踪 Zur Rose Group 的高管变动
药店
Zur Rose Group 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
药店 行业的其他推荐联系人
消息
Zur Rose Group 的最新新闻稿
- dmr Advertising, the 360° Retail Media Unit of DocMorris, announces strategic partnership with LiveRamp | DocMorris
- DocMorris accelerates Rx growth | DocMorris
- DocMorris calls for consistent pharmacy reform | DocMorris
- DocMorris grows in the prescription business and invests incrementally in new Rx customers | DocMorris
- dmr Advertising, the 360° Retail Media Unit of DocMorris, Expands Retail Media Offering with Criteo to Include Native Video Ads | DocMorris
- Even easier to save: DocMorris introduces new points system | DocMorris
- DocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025 | DocMorris
- DocMorris AG: Daniel Wüest becomes new CFO at DocMorris | DocMorris
- DocMorris successfully completes the placement of CHF 200 million Convertible Bonds due 2029 | DocMorris
- DocMorris AG: DocMorris receives gematik approval for simple digital e-prescription redemption via health card | DocMorris
- View more press releases Close
关于 Zur Rose Group 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Walter Hess 
